IP Library Granted Patent US 11,482,339
Granted Patent B2
US 11,482,339 · App. 16/875,607 · Granted Oct 25, 2022

Systems and methods for estimating hemodynamic forces acting on plaque and monitoring risk

Inventors: Bon-Kwon Koo (Redwood City, CA); Gilwoo Choi (Redwood City, CA); Hyun Jin Kim (Redwood City, CA); Charles A. Taylor (Redwood City, CA)
Assignee: Heartflow, Inc.
G16H50/50A61B5/026A61B5/02007A61B5/0215G16H50/20G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,482,339
App. No.
16/875,607
Granted
Oct 25, 2022
Kind
B2
Abstract

Computer-implemented methods are disclosed for estimating values of hemodynamic forces acting on plaque or lesions. One method includes: receiving one or more patient-specific parameters of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion; constructing a patient-specific geometric model of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion, using the received one or more patient-specific parameters; estimating, using one or more processors, the values of hemodynamic forces at one or more points on the patient-specific geometric model, using the patient-specific parameters and geometric model by measuring, deriving, or obtaining one or more of a pressure gradient and a radius gradient; and outputting the estimated values of hemodynamic forces to an electronic storage medium. Systems and computer readable media for executing these methods are also disclosed.

Claims (59)

1. A computer-implemented method for monitoring hemodynamic risk in a patient, the method comprising:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

2. The computer-implemented method of claim 1 , wherein the current physiological and/or blood supply characteristics of the patient are acquired during exercise by the patient.

3. The computer-implemented method of claim 1 , wherein the current physiological and or blood supply characteristics of the patient are acquired by a mobile device associated with the patient.

4. The computer-implemented method of claim 1 , wherein determining current hemodynamic characteristics of the patient includes:

determining simplified hemodynamics characteristics for at least a portion of the patient-specific geometric model; and

based on the determined simplified hemodynamics characteristics, determining hemodynamic characteristics for a further portion of the patient-specific geometric model at which the simplified hemodynamics characteristics are unknown.

5. The computer-implemented method of claim 4 , wherein determining hemodynamic characteristics for the further portion of the patient-specific geometric model includes employing a machine learning algorithm trained, based on patient-specific parameters of other patients and hemodynamic characteristics associated with one or more portions of patient-specific geometric models of the other patients, to determine hemodynamic characteristics for various portions of a given patient-specific geometric model.

6. The computer-implemented method of claim 1 , wherein obtaining the patient's maximum allowable hemodynamic characteristics includes:

obtaining patient-specific exercise-induced physiological stress characteristics for the patient;

based on the exercise-induced physiological stress characteristics and the one or more patient specific parameters, determining the patient's maximum allowable hemodynamic characteristics.

7. The computer-implemented method of claim 6 , wherein:

determining the patient's maximum allowable hemodynamic characteristics includes inputting the patient-specific exercise-induced physiological stress characteristics and the one or more patient-specific parameters into a trained machine learning algorithm; and

the trained machine learning algorithm is obtained based on one or more patient-specific parameters of a vascular system from each of a plurality of individuals with known values of hemodynamic forces.

8. The computer-implemented method of claim 6 , wherein obtaining the patient-specific exercise-induced physiological stress characteristics includes performing an exercise test on the patient.

9. The computer-implemented method of claim 6 , wherein the patient-specific exercise-induced physiological stress characteristics are determined based on patient medical records.

10. The computer-implemented method of claim 1 , wherein the warning includes a signal provided by a mobile device associated with the patient and/or a physician.

11. The computer implemented method of claim 1 , wherein the one or more patient-specific parameter include one or more measured, derived, or obtained geometric characteristics, plaque characteristics, coronary dynamics characteristics, patient characteristics, or a combination thereof.

12. The computer implemented method of claim 1 , wherein a three-dimensional patient specific model of blood flow includes blood flow through one or more of: a coronary vascular model; a cerebral vascular model; a peripheral vascular model; a hepatic vascular model; a renal vascular model; a visceral vascular model; or any vascular model with vessels supplying blood.

13. The computer implemented method of claim 1 , wherein obtaining the one or more patient-specific parameters includes acquiring a digital representation of the one or more patient-specific parameters using imaging, scanning, or measuring modalities, including, one or more of,

cardiac computerized tomography,

mobile devices and/or smartphones,

intravascular ultrasound (IVUS) imaging,

optical coherence tomography (OCT),

pressure wire measurements,

motorized pull-back measurements,

or a combination thereof.

14. A system for monitoring hemodynamic risk in a patient, the system comprising:

at least one memory storing instructions; and

at least one processor operatively connected to the memory and configured to execute the instructions to perform operations, including:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

15. The computer-implemented method of claim 14 , wherein the current physiological and/or blood supply characteristics of the patient are acquired during exercise by the patient.

16. The computer-implemented method of claim 14 , wherein the current physiological and or blood supply characteristics of the patient are acquired by a mobile device associated with the patient.

17. The computer-implemented method of claim 14 , wherein the warning includes a signal provided by a mobile device associated with the patient and/or a physician.

18. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for monitoring hemodynamic risk in a patient, the method comprising:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

19. The non-transitory computer readable medium of claim 18 , wherein the current physiological and/or blood supply characteristics of the patient are acquired by a mobile device associated with the patient during exercise by the patient.

20. The computer-implemented method of claim 19 , wherein the warning includes a signal provided by the mobile device associated with the patient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2025
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 072876/0775 →
RELEASE OF SECURITY INTEREST Recorded Jun 21, 2024
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 067801/0032 →
SECURITY INTEREST Recorded Jun 18, 2024
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 067775/0966 →
SECURITY INTEREST Recorded Jan 20, 2021
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 055037/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2020
From: KOO, BON-KWON; CHOI, GILWOO; KIM, HYUN JIN; TAYLOR, CHARLES A.
To: HEARTFLOW, INC.
Reel/Frame 052924/0507 →
Continuity (4)
Continuation 15201010 · Jul 1, 2016
Continuation 15199305 · Jun 30, 2016
Provisional Application 62192314 · Jul 14, 2015
Related Publication 20200279656A1 · Sep 3, 2020
Cited By (29)
US 12,229,957 US 12,236,595 US 12,245,882 US 12,283,046 US 12,299,885 US 12,315,076 US 12,324,695 US 12,324,696 US 12,354,755 US 12,380,560 US 12,387,325 US 12,396,695 US 12,406,365 US 12,408,885 US 12,423,813 US 12,440,180 US 12,446,965 US 12,499,539 US 12,499,646 US 12,512,196 US 12,531,159 US 12,555,228 US 12,558,048 US 12,567,489 US 12,599,352 US 12,620,092 US 12,635,965 US 12,712,082 US 12,714,382